Search

everythinglearnresearchcommunity

for

Search:↓

Not having the gene PLAAT3 leads to fat loss, high insulin resistance, and abnormal fat levels in the blood due to a disruption in fat cell development and function.

Tanning ability is linked to specific DNA changes in skin genes.

K10 may not prevent tumors as previously thought and might increase benign tumor risk.

Further testing of paclitaxel poliglumex for this cancer treatment is not justified.

Non-coding RNAs may be key in diagnosing and treating rare skin disorders.

Trichotillomania may have a genetic link to psychiatric disorders.

A gene mutation worsens skin irritation in mice due to a lack of certain fats.

The CTLA-4 gene change studied does not affect Polycystic Ovarian Syndrome in the women tested.

NKIRAS2 can suppress certain skin tumors but its effect on cancer varies with context and expression level.

Mutations in Gasdermin A3 cause skin inflammation and hair loss by disrupting mitochondria.

Skin lesions in Carney complex are likely caused by a specific group of skin cells that promote pigment production due to a genetic mutation.

Some skin tumors from hair follicles and glands can be linked to genetic syndromes and may be benign or malignant.

Scientists found gene mutations that affect hair loss, skin stem cells, and skin disorders, and identified drugs that may help treat blood vessel and skin conditions.

The document concludes that over 500 genes are linked to hair disorders and this knowledge is important for creating new treatments.

The document reports findings on genetic research, including ethical concerns about genome editing, improved diagnosis of mitochondrial mutations, solving inherited eye diseases, confirming gene roles in epilepsy, linking a gene to aneurysms, and identifying genes associated with age-related macular degeneration.

Trichothiodystrophy is a rare genetic disorder causing hair issues and sometimes linked to DNA repair defects.

REV7 is crucial for genome stability and cancer treatment, making it a potential target for therapy.

BMP signaling helps prevent skin tumors by blocking cancer-promoting pathways.

Most patients experienced mild to moderate skin problems during a trial for a desmoid tumor treatment.

PNKP is essential for keeping adult mouse progenitor cells healthy and growing normally.

Human and mouse TGase3 enzymes are similar but differ near the activation site, crucial for their function in skin and hair development.

Trypsin slows hair growth and affects color by causing cell death in hair follicles.

KRT17 may be a new target for endometrial cancer treatment because it helps cancer cells move and form new blood vessels.

Scarring alopecia involves increased immune cells and specific gene changes near damaged hair follicles.

A man with myotonic dystrophy type 1 had 28 skin cancers, suggesting a link between the disease and skin cancer, emphasizing the need for sun protection and regular skin checks.

Ripretinib is effective and safe for treating advanced GIST in Chinese patients, particularly for non-gastric GISTs.

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

The study found genetic differences related to hair development that may explain hair loss in a patient with Trichorhinophalangeal syndrome type I.

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.